No. A single 2026 case report does not show that psilocybin helps advanced Alzheimer’s; it describes one person’s improvements and cannot establish effectiveness or generalize to others.
The report notes short-term gains in communication, memory, emotional engagement, and daily function after ingesting psilocybin-containing mushrooms. With an uncontrolled single case, placebo effects, symptom fluctuation, and caregiver influences could also explain changes. I cannot independently verify outcomes beyond what the authors reported.
These observations are consistent with hypotheses about neuroplasticity, BDNF, and connectivity, but they remain unproven. Rigorous randomized trials are needed to test safety, dosing, durability, and who might benefit. Psilocybin is not an approved treatment for Alzheimer’s.
For details, see the 2026 Frontiers in Neuroscience case report. Interesting signal, not proof.